Results 1 to 10 of about 9,047 (170)

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025. [PDF]

CPT Pharmacometrics Syst Pharmacol
ABSTRACT Developed at Bayer Technology Services, PK‐Sim and MoBi transitioned into the Open Systems Pharmacology (OSP) Suite, released as free open‐source software in 2017. An active community with stakeholders from academia, industries, and regulators contributes to the continuous improvement of open‐source model‐informed drug development (MIDD). This
Cordes H, Annaert P, Balazki P, Benamara S, Bonan RH, Butler A, Chenel M, Cui Y, Dallmann A, de Witte WEA, Demeester C, Feick D, Gattacceca F, Geci R, Gerebtzoff G, Gruber A, Guimarães M, Hamadeh A, Hanke N, Ibarra M, Ince I, Kanacher T, Kuepfer L, Mil F, Montaseri G, Nauwelaerts N, Proenca S, Schaller S, Schlender JF, Schneider ARP, Sjögren E, Solodenko J, Staab A, Vrenken P, Troisi C, Teutonico D.   +35 more
europepmc   +2 more sources

Bioequivalence of netupitant and palonosetron (NEPA) oral suspension and hard capsules in healthy individuals: results from an open-label, randomized, two-treatment, four-period, two-sequence replicative design trial. [PDF]

Support Care Cancer
Gasanin E, Bezzo R, Spinelli T, Seitz F.
europepmc   +1 more source

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies. [PDF]

Ther Adv Respir Dis
Bednarczyk A, Aurivillius M, Jassal M, Shah M, Raphiou I, Petullo D, Xu J, Heijer M, Sychowicz K, Collison K, Silva C, Reddy J, Han D, Goldwater R, Gillen M, Patel M.   +15 more
europepmc   +1 more source

A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioequivalence study. [PDF]

Clin Pharmacol Drug Dev
Vyas N, Chakra A, Sarode P, Dharmadhikari S, Puppalwar G, Khandhedia C, Mane A, Goyani A, Khopade AJ.   +8 more
europepmc   +1 more source

Safety, Pharmacokinetics, and Bioequivalence Characterization of Two Different Strengths of Mesalazine Gastro-Resistant Tablets. [PDF]

Pharmaceuticals (Basel)
Ochoa Mazarro D, Román Martínez M, Martín Vílchez S, Luquero-Bueno S, Camargo-Mamani P, Frau Usoz M, Martínez Ostalé C, Arranz P, Gilaberte I.   +8 more
europepmc   +1 more source

Breaking barriers: how generic drugs democratize mental health. [PDF]

Front Pharmacol
Rosas-Sánchez GU, Mercado-Serna M, Fernández-Demeneghi R, Pérez-Vega MI, Soria-Fregozo C.   +4 more
europepmc   +1 more source

A Single Dose, Randomized, Open-Label, Cross-Over Bioequivalence Study of Budesonide Pressurized Metered-Dose Inhaler in Healthy Chinese Subjects. [PDF]

Pharmacol Res Perspect
Huang K, Yin S, Huang W, Ding L, Qin W, Qian Z, Ding Y, Que L, Shi Y, Gao J, Zhao Y.   +10 more
europepmc   +1 more source

Effectiveness of virtual simulation-based pre-learning and the mediating role of metacognition in pharmacokinetics laboratory education. [PDF]

BMC Med Educ
Hu X, Liu J, Wang J.
europepmc   +1 more source

Bioequivalence of Two Perampanel Oral Suspension Formulations in Healthy Subjects: A Randomized Crossover Study. [PDF]

Drugs R D
AbdelMagid AM, Badr KA, Rezk MR.
europepmc   +1 more source

Bioequivalence Between a Gantenerumab Disposable Syringe and an Autoinjector: A Randomized Controlled Trial in Healthy Volunteers. [PDF]

Clin Pharmacol Drug Dev
Schwab D, Hofmann C, Justies N, Dickerson DS, Keshavarz A, van Iersel T, Martens K, Bittner B.   +7 more
europepmc   +1 more source